Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
jueves, 17 de abril de 2025
Harnessing the Microbiome to Treat Melanoma: Can It Work? Manuela Callari April 10, 2025 ++++++
https://www.medscape.com/viewarticle/harnessing-microbiome-treat-melanoma-can-it-work-2025a10008lc?ecd=WNL_conf_onc_EADO-SPON_250417_MSCPEDIT_etid7364246&uac=148436CN&impID=7364246
Population vs Tailored Skin Cancer Screening: Which Is Best?
Manuela Callari
April 04, 2025
https://www.medscape.com/viewarticle/population-vs-tailored-skin-cancer-screening-which-best-2025a100084a?ecd=WNL_conf_onc_EADO-SPON_250417_MSCPEDIT_etid7364246&uac=148436CN&impID=7364246
Rising Skin Cancer Rates: Epidemic or Overdiagnosis?
Manuela Callari
April 09, 2025
https://www.medscape.com/viewarticle/rising-skin-cancer-rates-epidemic-or-overdiagnosis-2025a10008hm?ecd=WNL_conf_onc_EADO-SPON_250417_MSCPEDIT_etid7364246&uac=148436CN&impID=7364246
Assay Shows Promise for Early-Stage Melanoma Risk Assessment Beyond SNLB
Sharon Worcester, MA
April 07, 2025
https://www.medscape.com/viewarticle/assay-shows-promise-early-stage-melanoma-risk-assessment-2025a10008ap?ecd=WNL_conf_onc_EADO-SPON_250417_MSCPEDIT_etid7364246&uac=148436CN&impID=7364246
Immunotherapy Break Okay After Response in Metastatic Melanoma
Sharon Worcester
April 09, 2025
https://www.medscape.com/viewarticle/immunotherapy-break-okay-after-response-metastatic-melanoma-2025a10008i3?ecd=WNL_conf_onc_EADO-SPON_250417_MSCPEDIT_etid7364246&uac=148436CN&impID=7364246
Confirmed Benefit of Adjuvant Therapy, Not Nodal Dissection, in Stage III Melanoma
Manuela Callari
April 09, 2025
https://www.medscape.com/viewarticle/confirmed-benefit-adjuvant-therapy-not-nodal-dissection-2025a10008hg?ecd=WNL_conf_onc_EADO-SPON_250417_MSCPEDIT_etid7364246&uac=148436CN&impID=7364246
No hay comentarios:
Publicar un comentario